Chris Wagner

Biography

Mr. Wagner has more than 20 years of experience in  product development and commercialization  in the life sciences industry. In addition to his role at Contextual Genomics, Mr. Wagner also serves on several not for profit and industry boards. Prior to Contextual Genomics, Mr. Wagner served as the President and CEO of Sirius Genomics, a molecular diagnostics company where he saw the company through new strategy development, scientific discovery, equity capital raising, the world’s largest sepsis genomics clinical trial, and sale of the company. Mr. Wagner was previously with Aspreva Pharmaceuticals as a founding executive where he helped raise $190M in private and public financings and increased the company’s valuation from $3M to $1B. Prior to Aspreva, Mr. Wagner was with Eli Lilly working in Europe, North America and Asia. He worked on the development and commercialization of 15 products including biologics and small molecules with annual sales reaching over $4 billion.

Research Interest

  Product development, Commercialization Trategy Development, Scientific Discovery and Equity Capital Raising,